rationale serotonin pulmonary vasoconstrictor smooth muscle cell mitogen serotonin transporter sert abundant pulmonary vascular smooth muscle compared short s allele long l sert promoter allele associated increased sert transcription severe pulmonary hypertension cohort patients chronic obstructive pulmonary disease prevalent cohort idiopathic pulmonary arterial hypertension ipah compared control subjects objective hypothesized sert l allele associate earlier age diagnosis shorter survival interval pulmonary arterial hypertension pah s allele methods sert promoters NUMBER familial pah fpah NUMBER ipah NUMBER control subjects sequenced patients fpah known mutation bone morphogenetic protein receptor NUMBER bmpr2 results mean age diagnosis NUMBER yr patients fpah NUMBER yr patients ipah p NUMBER significant differences distribution ll ls ss genotypes ipah fpah unaffected bmpr2 mutation carriers fpah ll genotype associated earlier age diagnosis p NUMBER conclusions patients ipah sert genotypes correlate age diagnosis survival interval patients fpah ll genotype correlates earlier age diagnosis sl ss survival groups similar correlation sert promoter polymorphism age diagnosis fpah suggests possible relationship sert bmpr2 seven